• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗医护人员在新冠病毒非 mRNA 疫苗接种前后各个高峰期自然感染和突破性感染的发生率和症状。

The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers.

机构信息

Department of Virology, Professor Alborzi Clinical Microbiology Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, 71937-11351, Iran.

Department of Family Medicine and Infectious Disease, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Virol J. 2023 Aug 18;20(1):182. doi: 10.1186/s12985-023-02156-2.

DOI:10.1186/s12985-023-02156-2
PMID:37596593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436397/
Abstract

BACKGROUND/AIMS: The aim of this study was to determine the rate of natural and breakthrough infection and related symptoms of Covid-19 amongst Iranian healthcare workers (HCWs) who were vaccinated by different non-mRNA-based vaccines at peak points.

METHODS

In this cross-sectional study, the RT-PCR test was performed for a total of 10,581 HCWs suspicious of Covid-19 infection. For each HCW, the frequency of SARS-CoV-2 infection and the time of transmission based on vaccination administration time and schedule were examined during different waves of the pandemic. Based on these findings, the study patients were divided into three groups: natural, natural/breakthrough, and breakthrough.

RESULTS

In total, 53% of the HCWs were exposed to SARS-CoV-2 infection between 1 and 5 times within two years after the current pandemic, while 20.7% and 32.3% experienced natural and breakthrough SARS-CoV-2 infection, respectively. Only 6% of the breakthrough-infected HCWs had naturally contracted SARS-CoV-2 infection during the initial waves. The highest natural peaks of infection occurred during the interval administration of the first and second dose of the first vaccination series, while the single highest peak of breakthrough infection belonged to the Omicron wave. It occurred simultaneously with the administration of the third vaccination dose. On the other hand, the highest rate of reinfection was observed amongst people who had received the Sinopharm and Bharat vaccines full-doses.

CONCLUSION

This study compared the clinical differences between the two peaks of Omicron and Delta. This study indicates the rates of natural and breakthrough SARS-CoV-2 infections according to vaccination schedules and different waves of the pandemic.

摘要

背景/目的:本研究旨在确定在疫情高峰期接种不同非 mRNA 疫苗的伊朗医护人员(HCWs)中 COVID-19 的自然感染和突破性感染率及相关症状。

方法

在这项横断面研究中,对总共 10581 名疑似 COVID-19 感染的 HCWs 进行了 RT-PCR 检测。对于每一位 HCW,根据疫苗接种时间和时间表,检查了在不同疫情波次中 SARS-CoV-2 感染的频率和传播时间。基于这些发现,将研究患者分为三组:自然感染、自然/突破性感染和突破性感染。

结果

在两年内,共有 53%的 HCWs 被 SARS-CoV-2 感染了 1-5 次,其中 20.7%和 32.3%分别经历了自然和突破性 SARS-CoV-2 感染。只有 6%的突破性感染 HCWs 在初始波次中自然感染过 SARS-CoV-2。自然感染的最高峰发生在第一剂和第二剂第一针接种系列间隔期间,而突破性感染的单一最高峰则属于奥密克戎波次。它与第三剂疫苗接种同时发生。另一方面,全剂量接种国药和 Bharat 疫苗的人群中,再感染率最高。

结论

本研究比较了奥密克戎和德尔塔两个高峰的临床差异。本研究根据疫苗接种计划和不同的疫情波次,显示了自然和突破性 SARS-CoV-2 感染的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/10436397/a4116a3f7c62/12985_2023_2156_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/10436397/4e31214ce1dc/12985_2023_2156_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/10436397/a4116a3f7c62/12985_2023_2156_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/10436397/4e31214ce1dc/12985_2023_2156_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/10436397/a4116a3f7c62/12985_2023_2156_Fig2_HTML.jpg

相似文献

1
The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers.伊朗医护人员在新冠病毒非 mRNA 疫苗接种前后各个高峰期自然感染和突破性感染的发生率和症状。
Virol J. 2023 Aug 18;20(1):182. doi: 10.1186/s12985-023-02156-2.
2
Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).的里雅斯特教学医院(意大利东北部)医护人员中新冠病毒疫苗突破性感染的风险及相关因素
Viruses. 2022 Feb 7;14(2):336. doi: 10.3390/v14020336.
3
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.同时接种抗 SARS-CoV-2 和流感疫苗的医护人员的安全性概况和 SARS-CoV-2 突破感染:一项意大利观察性研究。
Vaccine. 2023 Aug 31;41(38):5655-5661. doi: 10.1016/j.vaccine.2023.07.043. Epub 2023 Aug 4.
4
SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.2020 年 3 月 1 日至 2023 年 1 月 31 日期间医护人员中 SARS-CoV-2 再感染情况。
Viruses. 2023 Jul 14;15(7):1551. doi: 10.3390/v15071551.
5
Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.2021 年 12 月 1 日至 2022 年 5 月 31 日,在意大利东北部的的里雅斯特和戈里齐亚的医护人员中,奥密克戎传播期间的 SARS-CoV-2 初次感染、再感染和疫苗有效性。
Viruses. 2022 Nov 30;14(12):2688. doi: 10.3390/v14122688.
6
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.接种疫苗的医护人员中突破性 SARS-CoV-2 感染的危险因素。
PLoS One. 2021 Oct 15;16(10):e0258820. doi: 10.1371/journal.pone.0258820. eCollection 2021.
7
COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.威尔士卫生保健工作者的 COVID-19 加强疫苗接种率和感染突破:一项全国前瞻性队列研究。
Vaccine. 2023 Feb 10;41(7):1378-1389. doi: 10.1016/j.vaccine.2023.01.023. Epub 2023 Jan 13.
8
Effectiveness of MRNA booster vaccine among healthcare workers in New York City during the Omicron surge, December 2021 to January 2022.2021 年 12 月至 2022 年 1 月奥密克戎疫情期间,纽约市医护人员接种 mRNA 加强疫苗的效果。
Clin Microbiol Infect. 2022 Dec;28(12):1624-1628. doi: 10.1016/j.cmi.2022.07.017. Epub 2022 Aug 3.
9
Pre-infection antibody levels of vaccinated healthcare workers with SARS-CoV-2 breakthrough infection: A nested case-control study.接种疫苗的医护人员感染 SARS-CoV-2 突破性感染的预感染抗体水平:一项巢式病例对照研究。
Immunol Lett. 2023 Oct;262:1-6. doi: 10.1016/j.imlet.2023.08.002. Epub 2023 Aug 18.
10
Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列医护人员接种第四剂 BNT162b 疫苗与 SARS-CoV-2 感染的关联。
JAMA Netw Open. 2022 Aug 1;5(8):e2224657. doi: 10.1001/jamanetworkopen.2022.24657.

引用本文的文献

1
COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.特立尼达和多巴哥的新冠疫苗有效性与安全性:一项系统评价与荟萃分析
Microorganisms. 2025 Jan 10;13(1):135. doi: 10.3390/microorganisms13010135.
2
COVID-19 vaccine updates for people under different conditions.不同人群的 COVID-19 疫苗更新信息。
Sci China Life Sci. 2024 Nov;67(11):2323-2343. doi: 10.1007/s11427-024-2643-1. Epub 2024 Jul 29.

本文引用的文献

1
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.在意大利 Delta 和奥密克戎变异株流行期间,接受疾病修正治疗的多发性硬化症患者在感染 COVID-19 后突破性感染 SARS-CoV-2。
EBioMedicine. 2022 Jun;80:104042. doi: 10.1016/j.ebiom.2022.104042. Epub 2022 May 5.
2
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.同源和异源加强针对于灭活 SARS-CoV-2 疫苗的有效性:一项大规模前瞻性队列研究。
Lancet Glob Health. 2022 Jun;10(6):e798-e806. doi: 10.1016/S2214-109X(22)00112-7. Epub 2022 Apr 23.
3
SARS-CoV-2 seroprevalence among healthcare workers.
SARS-CoV-2 血清抗体阳性率在医护人员中的情况。
PLoS One. 2022 Apr 25;17(4):e0266410. doi: 10.1371/journal.pone.0266410. eCollection 2022.
4
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.在南非西开普省,与之前的几波疫情相比,奥密克戎驱动的第四波疫情中实验室确诊的 SARS-CoV-2 感染的结果。
Trop Med Int Health. 2022 Jun;27(6):564-573. doi: 10.1111/tmi.13752. Epub 2022 May 10.
5
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
6
Factors Associated with SARS-CoV-2 Repeat Positivity - Beijing, China, June-September 2020.与新冠病毒重复阳性相关的因素——中国北京,2020年6月至9月
China CDC Wkly. 2022 Feb 4;4(5):88-95. doi: 10.46234/ccdcw2022.017.
7
Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea.韩国 40 例感染 SARS-CoV-2 奥密克戎变异株患者的临床特征。
J Korean Med Sci. 2022 Jan 17;37(3):e31. doi: 10.3346/jkms.2022.37.e31.
8
COVID-19 Prevalence among Healthcare Workers. A Systematic Review and Meta-Analysis.医护人员中的新冠病毒病(COVID-19)感染率:一项系统评价与荟萃分析
Int J Environ Res Public Health. 2021 Dec 23;19(1):146. doi: 10.3390/ijerph19010146.
9
The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries.强制性 COVID-19 证书对疫苗接种率的影响:六个国家的合成控制建模。
Lancet Public Health. 2022 Jan;7(1):e15-e22. doi: 10.1016/S2468-2667(21)00273-5. Epub 2021 Dec 13.
10
BNT162b2 Vaccine Booster and Mortality Due to Covid-19.BNT162b2 疫苗加强针与新冠病毒导致的死亡率。
N Engl J Med. 2021 Dec 23;385(26):2413-2420. doi: 10.1056/NEJMoa2115624. Epub 2021 Dec 8.